We are live on ! Find out more
CM

Castleark Management Portfolio holdings

AUM $3.71B
1-Year Est. Return 65.19%
This Fund
S&P 500
This Quarter Est. Return
+14.75%
1 Year Est. Return
+65.19%
3 Year Est. Return
+247.97%
5 Year Est. Return
+412.62%
10 Year Est. Return
+3,903.2%
AUM
$3.48B
AUM Growth
+$231M
Cap. Flow
-$87.3M
Cap. Flow %
-2.51%
Top 10 Hldgs %
17.4%
Holding
433
New
64
Increased
81
Reduced
104
Closed
64

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$29M
2
CNC icon
Centene
CNC
+$17.6M
3
KBR icon
KBR
KBR
+$16.5M
4
CDW icon
CDW
CDW
+$16.2M
5
IQV icon
IQVIA
IQV
+$16.1M

Top Sells

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$27M
2
PVH icon
PVH
PVH
+$18.7M
3
TPR icon
Tapestry
TPR
+$18.2M
4
IART icon
Integra LifeSciences
IART
+$18.1M
5
MTZ icon
MasTec
MTZ
+$17.7M

Sector Composition

Rank Sector Weight
1 Healthcare 24.56%
2 Technology 18%
3 Consumer Discretionary 12.44%
4 Industrials 12.24%
5 Energy 10.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NEWR
151
DELISTED
New Relic, Inc.
NEWR
$7.54M 0.22%
80,040
-3,225
-4% -$334K
ENS icon
152
EnerSys
ENS
$6.2B
$7.48M 0.21%
+85,805
New +$6.89M
IDTI
153
DELISTED
Integrated Device Technology I
IDTI
$7.47M 0.21%
158,975
-184,985
-54% -$7.15M
RCM
154
DELISTED
R1 RCM Inc. Common Stock
RCM
$7.46M 0.21%
+734,716
New +$6.69M
JAZZ icon
155
Jazz Pharmaceuticals
JAZZ
$15.8B
$7.41M 0.21%
44,055
+260
+0.6% +$44.7K
LPSN
156
DELISTED
LivePerson
LPSN
$7.39M 0.21%
18,983
-4,517
-19% -$1.67M
CDXS icon
157
Codexis
CDXS
$147M
$7.32M 0.21%
426,648
-6,630
-2% -$107K
SPSC icon
158
SPS Commerce
SPSC
$2.9B
$7.19M 0.21%
144,978
-2,260
-2% -$101K
BAC icon
159
Bank of America
BAC
$405B
$7.16M 0.21%
242,900
– –
TPIC
160
DELISTED
TPI Composites
TPIC
$7.15M 0.21%
+250,283
New +$7.25M
PETQ
161
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$7.05M 0.2%
+179,277
New +$5.97M
AGS
162
DELISTED
PlayAGS
AGS
$7M 0.2%
237,555
+33,005
+16% +$977K
ASB icon
163
Associated Banc-Corp
ASB
$5.62B
$6.93M 0.2%
266,670
-4,140
-2% -$113K
JPM icon
164
JPMorgan Chase
JPM
$927B
$6.88M 0.2%
61,000
– –
RIG icon
165
Transocean
RIG
$6.19B
$6.8M 0.2%
487,320
– –
ICLR icon
166
Icon
ICLR
$13.4B
$6.78M 0.19%
44,105
-3,715
-8% -$533K
CSII
167
DELISTED
Cardiovascular Systems, Inc.
CSII
$6.73M 0.19%
+172,030
New +$6.36M
VEEV icon
168
Veeva Systems
VEEV
$42.9B
$6.67M 0.19%
61,250
-127,858
-68% -$11.6M
LDOS icon
169
Leidos
LDOS
$16.2B
$6.55M 0.19%
+94,750
New +$6.43M
BNFT
170
DELISTED
Benefitfocus, Inc.
BNFT
$6.54M 0.19%
+161,585
New +$6.22M
BRO icon
171
Brown & Brown
BRO
$22B
$6.49M 0.19%
219,495
-18,555
-8% -$552K
TMX
172
DELISTED
Terminix Global Holdings, Inc.
TMX
$6.47M 0.19%
155,839
+3,337
+2% +$134K
NICE icon
173
Nice
NICE
$6.18B
$6.16M 0.18%
53,815
+26,750
+99% +$2.99M
XOM icon
174
ExxonMobil
XOM
$672B
$6.11M 0.18%
71,850
+35,040
+95% +$2.86M
HMSY
175
DELISTED
HMS Holdings Corp.
HMSY
$6.08M 0.17%
+185,255
New +$5.36M
5 6
7
8 9

Similar funds

MSC
MUFG Securities (Canada) New York $3.71B AUM 38.19% 1-Year Est. Return
BC
Burney Company Reston, Virginia $3.71B AUM 37.66% 1-Year Est. Return
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
HCM
Himalaya Capital Management Seattle, Washington $3.7B AUM 39.18% 1-Year Est. Return
OH
Osiris Holdings Monaco $3.72B AUM
BCM
Becker Capital Management Portland, Oregon $3.72B AUM 31.98% 1-Year Est. Return
CCI
Cevian Capital II St. Helier, Jersey $3.7B AUM 32.64% 1-Year Est. Return
MCM
MKP Capital Management New York $3.7B AUM 23.18% 1-Year Est. Return

Castleark Management's Q3 2018 Portfolio in Review

As of Q3 2018, Castleark Management held 433 positions worth $3.48B, up 7.1% from $3.25B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Castleark Management's Q3 2018 filing shows 64 new, 81 increased, 104 reduced and 64 closed positions. Its largest new stake was Eli Lilly: 289,654 shares worth $31.1M. The largest sale was Charles Schwab, an estimated $27M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 21% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Castleark Management's largest Q3 2018 buy was Eli Lilly: 289,654 shares worth $31.1M.
  • Castleark Management added most to CDW in Q3 2018, an estimated $16.2M increase.
  • Castleark Management's biggest Q3 2018 reduction was Charles Schwab, cutting an estimated $27M.
  • Castleark Management fully exited Tapestry in Q3 2018, selling an estimated $18.2M.
  • Castleark Management's ten largest holdings make up 17% of its $3.48B portfolio in Q3 2018.
  • Castleark Management opened 64 new positions and closed 64 in Q3 2018.
  • Castleark Management's portfolio value rose 7.1% quarter-over-quarter to $3.48B.

Based on Castleark Management's 13F filing for Q3 2018, filed 15 Nov 2018.